Advertisement
Review Article| Volume 27, ISSUE 1, P47-55, February 2023

Pruritus in Chronic Liver Disease

Published:October 17, 2022DOI:https://doi.org/10.1016/j.cld.2022.08.011

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bhalerao A.
        • Mannu G.S.
        Management of pruritus in chronic liver disease.
        Dermatol Res Pract. 2015; 2015: 295891https://doi.org/10.1155/2015/295891
        • Tajiri K.
        • Shimizu Y.
        Recent advances in the management of pruritus in chronic liver diseases.
        World J Gastroenterol. 2017; 23: 3418-3426
        • Dega H.
        • Francès C.
        • Dupin N.
        • et al.
        Prurit et virus de l'hépatite C. Le Groupe Multivirc [Pruritus and the hepatitis C virus. The MULTIVIRC Unit].
        Ann Dermatol Venereol. 1998; 125 (French. PMID: 9747198): 9-12
        • Montagnese S.
        • Nsemi L.M.
        • Cazzagon N.
        • et al.
        Sleep-Wake profiles in patients with primary biliary cirrhosis.
        Liver Int. 2013; 33 (Epub 2012 Nov 22. PMID: 23173839): 203-209
        • Oeda S.
        • Takahashi H.
        • Yoshida H.
        • et al.
        Prevalence of pruritus in patients with chronic liver disease: a multicenter study.
        Hepatol Res. 2018; 48: E252-E262https://doi.org/10.1111/hepr.12978
        • Langedijk J.A.G.M.
        • Beuers U.H.
        • Oude Elferink R.P.J.
        Cholestasis-associated pruritus and its pruritogens.
        Front Med (Lausanne). 2021; 8: 639674https://doi.org/10.3389/fmed.2021.639674
        • Ghent C.N.
        Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin.
        Am J Gastroenterol. 1987; 82 (PMID: 3812415): 117-118
        • Kittaka H.
        • Uchida K.
        • Fukuta N.
        • et al.
        Lysophosphatidic acid-induced itch is mediated by signalling of LPA.
        J Physiol. 2017; 595: 2681-2698
        • Kremer A.E.
        • et al.
        Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
        Gastroenterology. 2010; 139: 1008-1018
        • Wunsch E.
        • Krawczyk M.
        • Milkiewicz M.
        • et al.
        Serum autotaxin is a Marker of the severity of liver injury and overall Survival in patients with cholestatic liver diseases.
        Sci Rep. 2016; 6: 30847https://doi.org/10.1038/srep30847
        • Jones E.A.
        • Bergasa N.V.
        The pruritus of cholestasis: from bile acids to opiate agonists.
        Hepatology. 1990; 11: 884-887
        • Beuers U.
        • Kremer A.E.
        • Bolier R.
        • et al.
        Pruritus in cholestasis: Facts and fiction.
        Hepatology. 2014; 60: 399-407
        • Peters M.G.
        • Di Bisceglie A.M.
        • Kowdley K.V.
        • et al.
        Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.
        Hepatology. 2007; 46: 769-775
        • Abedin P.
        • Weaver J.B.
        • Egginton E.
        Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution.
        Ethn Health. 1999; 4: 35-37
        • Yosipovitch G.
        • Bernhard J.D.
        Clinical practice. Chronic pruritus.
        N Engl J Med. 2013; 368: 1625-1634
        • Zein C.O.
        • Lindor K.D.
        Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
        Curr Gastroenterol Rep. 2010; 12: 13-22
        • Glantz A.
        • Reilly S.-J.
        • Benthin L.
        • et al.
        Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
        Hepatology. 2008; 47: 544-551
        • di Padova C.
        • Tritapepe R.
        • Rovagnati P.
        • et al.
        Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids.
        Methods Findings Exp Clin Pharmacol. 1984; 6: 773-776
        • Duncan J.S.
        • Kennedy H.J.
        • Triger D.R.
        Treatment of pruritus due to chronic obstructive liver disease.
        Br Med J. 1984; 288: 22
        • Jacobson T.A.
        • Armani A.
        • McKenney J.M.
        • et al.
        Safety considerations with gastrointestinally active lipid-lowering drugs.
        Am J Cardiol. 2007; 99: 47C-55C
        • Levy C.
        • Lindor K.D.
        Current management of primary biliary cirrhosis and primary sclerosing cholangitis.
        J Hepatol. 2003; 38: S24-S37
        • Price T.J.
        • Patterson W.K.
        • Olver I.N.
        Rifampicin as treatment for pruritus in malignant cholestasis.
        Support Care Cancer. 1998; 6: 533-535
        • Prince M.I.
        • Burt A.D.
        • Jones D.E.J.
        Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
        Gut. 2002; 50: 436-439
        • Bergasa N.V.
        • Ailing D.W.
        • Talbot T.L.
        • et al.
        Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial.
        Ann Intern Med. 1995; 123: 161-167
        • Phan N.Q.
        • Bernhard J.D.
        • Luger T.A.
        • et al.
        Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
        J Am Acad Dermatol. 2010; 63: 680-688
        • Mayo M.J.
        • Handem I.
        • Saldana S.
        • et al.
        Sertraline as a first-line treatment for cholestatic pruritus.
        Hepatology. 2007; 45: 666-674
        • Sola C.L.
        • Bostwick J.M.
        • Hart D.A.
        • et al.
        Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise.
        Mayo Clin Proc. 2006 Mar; 81: 330-334
        • Adams F.
        The extant works of aretaeus, the cappadocian.
        Sydenham Society, London, UK1865
        • Heerkens M.
        • Dedden S.
        • Scheepers H.
        • et al.
        Effect of plasmapheresis on cholestatic pruritus and autotaxin Activity during pregnancy.
        Hepatology. 2019; 69: 2707-2710
        • Pinheiro N.C.
        • Marinho R.T.
        • Ramalho F.
        • et al.
        Refractory pruritus in primary biliary cirrhosis.
        BMJ Case Rep. 2013; 2013 (bcr2013200634)https://doi.org/10.1136/bcr-2013-200634
        • Hegade V.S.
        • Krawczyk M.
        • Kremer A.E.
        • et al.
        The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study.
        Aliment Pharmacol Ther. 2016; 43: 294-302
        • Carpentier B.
        • Gautier A.
        • Legallais C.
        Artificial and bioartificial liver devices: present and future.
        Gut. 2009 Dec; 58: 1690-1702
        • Pinheiro N.C.
        • Marinho R.T.
        • Ramalho F.
        • et al.
        Refractory pruritus in primary biliary cirrhosis.
        BMJ Case Rep. 2013; 2013 (bcr2013200634)
        • Ständer S.
        • Augustin M.
        • Reich A.
        • Ständer S, Augustin M, Reich A,
        International Forum for the Study of Itch Special Interest Group Scoring Itch in Clinical Trials. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials.
        Acta Derm Venereol. 2013; 93: 509-514